EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy and Safety of DOACs for the Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis

Andrea Boccatonda, Alice Brighenti, Chiara Simion, Paolo Simioni, Elena Campello

Thrombosis and Haemostasis · 2026-08 · 126 (08) · 832-842

DOI: 10.1055/a-2788-3034 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 27.01.2026. Verfasst von Andrea Boccatonda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Bolo…. Hauptthemen laut MEDLINE: Anticoagulants, Factor Xa Inhibitors, Venous Thromboembolism, Venous Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Direct oral anticoagulants (DOACs) are increasingly used for superficial vein thrombosis (SVT), yet evidence remains limited. This systematic review and meta-analysis synthesizes all available data on the efficacy and safety of DOACs in SVT. A systematic search identified randomized and observational studies enrolling adults with acute SVT treated with DOACs. Primary efficacy outcomes were venous thromboembolism (VTE: deep vein thrombosis or pulmonary embolism) and SVT recurrence/extension. Safety outcomes included major and clinically relevant non-major bleeding (CRNMB). Six studies (n = 2,040; 602 DOAC-treated patients) met the inclusion criteria. Compared with fondaparinux, DOACs showed comparable short-term efficacy for VTE prevention (pooled risk ratio [RR] 0.93, 95% CI 0.44–1.99) and similar rates of SVT recurrence (RR 1.30, 95% CI 0.65–2.62). Versus placebo, rivaroxaban reduced recurrence by approximately 80% (RR 0.20, 95% CI 0.03–1.35). In the pooled safety analysis including four studies, DOACs were associated with a 65% relative risk reduction in major or CRNMB compared with fondaparinux or low-molecular-weight heparin (RR 0.35, 95% CI 0.15–0.83; I 2 = 0%). In the TROLL registry (n = 229; 74% DOAC), no major bleeding occurred among DOAC users, while 5-year cumulative VTE and SVT recurrence rates were each 15.9%. Certainty of evidence was moderate for efficacy and high for safety. DOACs demonstrate efficacy comparable to fondaparinux and an excellent safety profile in SVT, supporting their use as a practical oral alternative. Long-term data indicate persistent thrombotic risk, suggesting potential benefit of extended low-dose prophylaxis in selected high-risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsFactor Xa InhibitorsVenous ThromboembolismVenous ThrombosisHumansAdministration, OralFondaparinuxHemorrhagePolysaccharidesPulmonary EmbolismRandomized Controlled Trials as TopicRecurrenceRivaroxabanTreatment Outcome

Substanzen

AnticoagulantsFactor Xa InhibitorsFondaparinuxPolysaccharidesRivaroxaban

Autor:innen und Institutionen

  • Diagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
  • Department of Medicine, General Medicine and Thrombotic and Hemorrhagic Diseases Unit, University Hospital of Padova, Padova, Italy.

Zitieren

APA

Boccatonda, A., Brighenti, A., Simion, C., Simioni, P., & Campello, E. (2026). Efficacy and Safety of DOACs for the Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis, 126(08), 832-842. https://doi.org/10.1055/a-2788-3034

Vancouver

Boccatonda A, Brighenti A, Simion C, Simioni P, Campello E. Efficacy and Safety of DOACs for the Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis. 2026;126(08):832-842. doi:10.1055/a-2788-3034

BibTeX
@article{Boccatonda2026,
  author = {Boccatonda, Andrea and Brighenti, Alice and Simion, Chiara and Simioni, Paolo and Campello, Elena},
  title = {Efficacy and Safety of DOACs for the Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {08},
  pages = {832--842},
  doi = {10.1055/a-2788-3034}
}
Kostenlos starten →